XML 98 R58.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Investments in Unconsolidated Joint Ventures (Combined Financial Information Income Statement) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Equity method investment, summarized financial information, income statement [Abstract]                      
Revenues                 $ 620,513 $ 601,272 $ 586,499
Maintenance, taxes, utilities, promotion, and other operating expenses                 226,014 211,285 218,004
Equity Method Investment Summarized Financial Information Impairment Charges                 6,154    
Interest expense                 139,756 132,669 130,339
Depreciation and amortization                 131,223 131,884 127,625
Total operating costs                 503,147 475,838 475,968
Nonoperating income, net                 2,870 1,923 2,894
Income tax expense                 (8,541) (5,935) (5,226)
Gain on disposition, net of tax (2)                 3,713
Net income                 111,695 121,422 111,912
Net income attributable to TRG                 58,020 62,964 59,994
Realized intercompany profit, net of depreciation on TRG’s basis adjustments                 5,698 8,386 9,326
Depreciation of TCO's additional basis                 (1,946) (1,946) (1,946)
Equity Method Investment Difference Between Net Income Attributable To Operating Partnership And Equity In Income Of Unconsolidated Joint Ventures Impairment Of Company's Additional Basis                 (12,606)    
Equity in income of Unconsolidated Joint Ventures $ (580) $ 20,252 $ 14,822 $ 14,672 $ 18,724 $ 16,910 $ 14,042 $ 19,728 49,166 69,404 67,374
Beneficial interest in Unconsolidated Joint Ventures’ operations:                      
Revenues less maintenance, taxes, utilities, promotion, and other operating expenses                 212,057 209,423 202,332
Interest expense                 (69,749) (68,225) (67,283)
Depreciation and amortization                 (71,583) (68,894) (66,933)
Income Loss From Equity Method Investments Potion Due To Impairment                 (17,951)    
Income tax expense                 (3,608) (2,900) (2,825)
Gain on disposition, net of tax (1)                   $ 2,083
Equity Method Investment, Realized Gain (Loss) on Disposal